Legacy Wealth Asset Management LLC lowered its holdings in Perrigo Company plc (NYSE:PRGO – Free Report) by 6.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,324 shares of the company’s stock after selling 1,195 shares during the period. Legacy Wealth Asset Management LLC’s holdings in Perrigo were worth $445,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Versant Capital Management Inc purchased a new stake in shares of Perrigo in the fourth quarter valued at $45,000. GAMMA Investing LLC boosted its holdings in Perrigo by 93.7% in the fourth quarter. GAMMA Investing LLC now owns 1,920 shares of the company’s stock valued at $49,000 after acquiring an additional 929 shares during the last quarter. Central Pacific Bank Trust Division boosted its holdings in Perrigo by 33.3% in the fourth quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company’s stock valued at $51,000 after acquiring an additional 500 shares during the last quarter. Venturi Wealth Management LLC acquired a new position in Perrigo in the third quarter valued at $56,000. Finally, KBC Group NV boosted its holdings in Perrigo by 25.1% in the third quarter. KBC Group NV now owns 4,517 shares of the company’s stock valued at $118,000 after acquiring an additional 905 shares during the last quarter. Hedge funds and other institutional investors own 95.91% of the company’s stock.
Perrigo Trading Up 0.0 %
Shares of PRGO opened at $23.86 on Friday. The stock’s 50-day moving average is $26.49 and its two-hundred day moving average is $26.73. The stock has a market cap of $3.26 billion, a PE ratio of -20.40 and a beta of 0.53. Perrigo Company plc has a 12 month low of $23.14 and a 12 month high of $33.96. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77.
Perrigo Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Friday, November 29th were given a dividend of $0.276 per share. This represents a $1.10 dividend on an annualized basis and a dividend yield of 4.63%. The ex-dividend date of this dividend was Friday, November 29th. Perrigo’s payout ratio is -94.02%.
Wall Street Analyst Weigh In
PRGO has been the topic of a number of research analyst reports. StockNews.com cut Perrigo from a “buy” rating to a “hold” rating in a report on Saturday, January 11th. Piper Sandler cut Perrigo from an “overweight” rating to a “neutral” rating and reduced their target price for the company from $34.00 to $27.00 in a report on Monday, January 6th. Argus cut Perrigo from a “buy” rating to a “hold” rating in a report on Tuesday. Canaccord Genuity Group reiterated a “buy” rating and issued a $42.00 target price on shares of Perrigo in a report on Monday, September 30th. Finally, Jefferies Financial Group restated a “hold” rating and set a $30.00 price objective (down previously from $50.00) on shares of Perrigo in a research note on Monday, September 23rd. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $35.00.
Get Our Latest Research Report on PRGO
Insider Transactions at Perrigo
In related news, Director Jeffrey B. Kindler sold 17,598 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $28.27, for a total value of $497,495.46. Following the completion of the sale, the director now directly owns 5,409 shares of the company’s stock, valued at $152,912.43. The trade was a 76.49 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.70% of the company’s stock.
Perrigo Profile
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Recommended Stories
- Five stocks we like better than Perrigo
- Best Stocks Under $5.00
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- The How and Why of Investing in Gold Stocks
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Want to Profit on the Downtrend? Downtrends, Explained.
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.